MetaCap

Fidelity Disruptive Medicine ETF (FMED)

NASDAQ: FMEDFidelity InvestmentsHealthETFUSD

31.40+0.9703 (+3.19%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

FMED chart

Full chart

Key facts

Holdings
9
Inception
Apr 16, 2020
Issuer
Fidelity Investments
Index tracked
—
Category
Health
52-week range
23.48 – 32.99
Volume / Avg
1.98K / 6.89K
Beta
—
Previous close
30.43

FMED ETF today

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund from Fidelity Investments in the Health category. It charges an expense ratio of 0.50%, or $50.00 per year on a $10,000 investment, and manages $52.3 million in assets. Its largest holding is 10x Genomics Inc Ordinary Shares - Class A (TXG) at 5.79% of assets, and the top 9 positions make up 33.0% of the portfolio out of 9 holdings.

FMED launched on Apr 16, 2020.

Summary generated from market data by MetaCap's automated system. Methodology

FMED top 10 holdings

FMED holdings by weight
#HoldingWeight
1TXG10x Genomics Inc Ordinary Shares - Class A5.79%
2NTRANatera Inc4.43%
3TMOThermo Fisher Scientific Inc4.13%
4DHRDanaher Corp3.81%
5ILMNIllumina Inc3.56%
6ARGXargenx SE ADR2.93%
7LFSTLifeStance Health Group Inc Ordinary Shares2.87%
8RVMDRevolution Medicines Inc Ordinary Shares2.83%
9DIM.PASartorius Stedim Biotech SA2.67%

Top 10 holdings: 33.0% of assets.

FMED performance

1 week

+1.12%

FMED price return, excluding dividends.

ETFs similar to FMED

FMED ETF FAQ

What is the FMED price today?

FMED last traded at $31.40 as of Oct 9, 4:00 PM EDT, up 3.19% on the day.

What is FMED's expense ratio?

FMED has an expense ratio of 0.50%, which works out to about $50.00 per year for every $10,000 invested.

What are FMED's top holdings?

FMED's largest holdings are 10x Genomics Inc Ordinary Shares - Class A (5.79%), Natera Inc (4.43%), Thermo Fisher Scientific Inc (4.13%), Danaher Corp (3.81%), Illumina Inc (3.56%). The top 10 make up 33.0% of the fund.

How big is FMED?

FMED has about $52.3 million in assets under management spread across 9 holdings.

Explore